Manufacturer record

Cooper Pharma Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Cooper Pharma Ltd (Uttarakhand) were declared Not of Standard Quality between May 2022 and May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: LM18898, Buprenorphin Injection I.P. (Noophin Injection) (exp Oct 2028). CDL, Kolkata (CDSCO lab) found it not of standard quality: Related Substances, Particulate matter, Sterility, Assay of Buprenorphine Hydrochloride eq. to Buprenorphine and Description. Listed in the May 2025 alert.

Records by type

3 records linked to Cooper Pharma Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, May 2022 to May 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2022
2
Products affected
Assay
Most common failure
May 2025
Latest alert

Flagged batches per year

2022 · 22025 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Buprenorphin Injection I.P. (Noophin Injection) Batch LM18898Mfg Nov 2022 · Exp Oct 2028 Related Substances, Particulate matter, Sterility, Assay of Buprenorphine Hydrochloride eq. to Buprenorphine and DescriptionAssay CDL, KolkataCDSCO lab May 2025
BUPRENORPHINE INJECTION I.P. Batch LM 18870Mfg Dec 2020 · Exp Nov 2026 AssayAssay RDTL GuwahatiState lab May 2022
BUPRENORPHINE INJECTION I.P. Batch LM 18730Mfg Aug 2018 · Exp Jul 2024 AssayAssay RDTL GuwahatiState lab May 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.